Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Russell 2000 Ishares ETF (IWM)

Russell 2000 Ishares ETF (IWM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Trump Sued By Small Businesses Over Tariffs, Alleging Misuse Of Emergency Economic Powers

According to CNBC, five small companies represented by the Liberty Justice Center, a nonprofit legal aid group, filed the lawsuit in the U.S. Court of International Trade.

IWO : 240.86 (+0.71%)
IWM : 186.48 (+0.82%)
VTWO : 75.38 (+0.92%)
FDA Approves Mirum Pharmaceuticals’ Drug For Rare Liver Disease Patients In Tablet Form: Retail Stays Bullish

Livmarli tablets will be available in June through Mirum Access Plus pharmacy.

MIRM : 39.10 (+0.90%)
VTI : 258.75 (+0.21%)
IWM : 186.48 (+0.82%)
Fate Therapeutics Stock Draws Investor Attention After FDA Grants Special Designation To Its CAR T-Cell Therapy: Retail Stays Optimistic

CEO Bob Valamehr said the RMAT designation recognises the therapy's potential in treating lupus.

VTI : 258.75 (+0.21%)
FATE : 1.1100 (+5.71%)
IWM : 186.48 (+0.82%)
ThredUp Stock Is Staring Down New 52-Week Highs

ThredUp (TDUP) has strong technical indicators, is trading above its daily moving averages, and has a 100% technical “buy” signal. The company faces tough competition, but it has also demonstrated...

EBAY : 66.26 (+1.21%)
RSG : 243.28 (-0.14%)
REAL : 5.38 (+4.87%)
TDUP : 3.32 (+1.22%)
IWM : 186.48 (+0.82%)
Soleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s Unmoved

VYKAT XR has now been delivered to the first individuals living with PWS who have been prescribed the medication, the company said.

VTI : 258.75 (+0.21%)
SLNO : 69.98 (+0.07%)
IWM : 186.48 (+0.82%)
Third Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 39% Pre-Market, But Retail’s Shattered

The company plans to file a certification of dissolution with the Secretary of the State of Delaware in the third quarter of 2025, provided that stockholders authorize the decision at its annual meeting...

THRD : 5.16 (+0.58%)
VTI : 258.75 (+0.21%)
IWM : 186.48 (+0.82%)
Keros Therapeutics Adopts Defense Strategy Against Potential Hostile Takeover, Explores Sale: Retail’s Overjoyed

The company said the plan aims to reduce the likelihood of any entity or person gaining control of Keros through open-market accumulation without paying all stockholders an appropriate control premium....

KROS : 14.07 (+3.99%)
VTI : 258.75 (+0.21%)
IWM : 186.48 (+0.82%)
Lumen Technologies Sees Nearly 500% Spike In Retail Chatter After Google Partnership

Lumen Tech said it was partnering with Google Cloud to deliver “advanced cloud and network solutions that meet the rising demands of enterprise customers.”

LUMN : 3.29 (+0.30%)
SKYY : 95.35 (-0.34%)
IWM : 186.48 (+0.82%)
PacBio Stock Soars On Plans To Reduce Spending Over NIH Funding Uncertainty, Tariffs: Retail Is Overjoyed

The company said that the decision is in response to uncertainty surrounding academic and National Institutes of Health (NIH) funding and the introduction of new tariffs under the Trump administration....

PACB : 1.1700 (-2.50%)
VTI : 258.75 (+0.21%)
IWM : 186.48 (+0.82%)
CorMedix Stock Rises After Preliminary Q1 Results Exceeds Expectations: Retail’s Elated

The company expects quarterly adjusted earnings before interest, taxes, depreciation, and amortisation (EBITDA) to exceed $22.5 million once final numbers are reported, exceeding expectations of $14.78...

CRMD : 7.67 (+1.99%)
VTI : 258.75 (+0.21%)
IWM : 186.48 (+0.82%)

Barchart Exclusives

Streak Analysis Alert: Why Merck (MRK) Should Be on Your Radar This Week
Blue chips like MRK stock generally represent a 50/50 wager for any given week. However, certain conditions strongly tilt the odds toward one side of the spectrum. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar